These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1315 related articles for article (PubMed ID: 27287253)

  • 1. Iron overload inhibits osteogenic commitment and differentiation of mesenchymal stem cells via the induction of ferritin.
    Balogh E; Tolnai E; Nagy B; Nagy B; Balla G; Balla J; Jeney V
    Biochim Biophys Acta; 2016 Sep; 1862(9):1640-9. PubMed ID: 27287253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells.
    Tsao YT; Shih YY; Liu YA; Liu YS; Lee OK
    Stem Cell Res Ther; 2017 Feb; 8(1):39. PubMed ID: 28222767
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells.
    Zhong S; He X; Li Y; Lou X
    Tissue Eng Regen Med; 2019 Apr; 16(2):141-150. PubMed ID: 30989041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caffeine regulates osteogenic differentiation and mineralization of primary adipose-derived stem cells and a bone marrow stromal cell line.
    Su SJ; Chang KL; Su SH; Yeh YT; Shyu HW; Chen KM
    Int J Food Sci Nutr; 2013 Jun; 64(4):429-36. PubMed ID: 23301724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pilose antler aqueous extract promotes the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells by stimulating the BMP-2/Smad1, 5/Runx2 signaling pathway.
    Ren C; Gong W; Li F; Xie M
    Chin J Nat Med; 2019 Oct; 17(10):756-767. PubMed ID: 31703756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
    Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
    Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
    Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
    FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-155 inhibits the osteogenic differentiation of mesenchymal stem cells induced by BMP9 via downregulation of BMP signaling pathway.
    Liu H; Zhong L; Yuan T; Chen S; Zhou Y; An L; Guo Y; Fan M; Li Y; Sun Y; Li W; Shi Q; Weng Y
    Int J Mol Med; 2018 Jun; 41(6):3379-3393. PubMed ID: 29512689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol alleviates osteoporosis through improving the osteogenic differentiation of bone marrow mesenchymal stem cells.
    Chen XH; Shi ZG; Lin HB; Wu F; Zheng F; Wu CF; Huang MW
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6352-6359. PubMed ID: 31364143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decrease of MiR-31 induced by TNF-α inhibitor activates SATB2/RUNX2 pathway and promotes osteogenic differentiation in ethanol-induced osteonecrosis.
    Yu L; Xu Y; Qu H; Yu Y; Li W; Zhao Y; Qiu G
    J Cell Physiol; 2019 Apr; 234(4):4314-4326. PubMed ID: 30132874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pax2 is essential for proliferation and osteogenic differentiation of mouse mesenchymal stem cells via Runx2.
    Lu M; Guo S; Hong F; Zhang Y; Yuan L; Ma C; Ma J
    Exp Cell Res; 2018 Oct; 371(2):342-352. PubMed ID: 30144446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR‑29b promotes the osteogenic differentiation of mesenchymal stem cells derived from human adipose tissue via the PTEN/AKT/β‑catenin signaling pathway.
    Xia T; Dong S; Tian J
    Int J Mol Med; 2020 Aug; 46(2):709-717. PubMed ID: 32468003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of zinc fingers and homeoboxes 3 on the regulation of mesenchymal stem cell osteogenic differentiation.
    Suehiro F; Nishimura M; Kawamoto T; Kanawa M; Yoshizawa Y; Murata H; Kato Y
    Stem Cells Dev; 2011 Sep; 20(9):1539-47. PubMed ID: 21174497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ferritin ferroxidase activity: a potent inhibitor of osteogenesis.
    Zarjou A; Jeney V; Arosio P; Poli M; Zavaczki E; Balla G; Balla J
    J Bone Miner Res; 2010 Jan; 25(1):164-72. PubMed ID: 19821764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heraclenin promotes the osteogenic differentiation of bone marrow stromal cells by activating the RhoA/ROCK pathway.
    Yu Z; Yuan J; Yu Y
    Histol Histopathol; 2024 Aug; 39(8):1065-1077. PubMed ID: 38258549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells.
    Shih YR; Tseng KF; Lai HY; Lin CH; Lee OK
    J Bone Miner Res; 2011 Apr; 26(4):730-8. PubMed ID: 20939067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of xylosyltransferase I correlate with the mineralization of the extracellular matrix during osteogenic differentiation of mesenchymal stem cells.
    Müller B; Prante C; Gastens M; Kuhn J; Kleesiek K; Götting C
    Matrix Biol; 2008 Mar; 27(2):139-49. PubMed ID: 17980567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR‑217 inhibits osteogenic differentiation of rat bone marrow‑derived mesenchymal stem cells by binding to Runx2.
    Zhu YL; Wang S; Ding DG; Xu L; Zhu HT
    Mol Med Rep; 2017 May; 15(5):3271-3277. PubMed ID: 28339007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [REGUL ATORY EFFECT OF SIMVASTATIN ON MIDDLE/L ATE STAGES OSTEOGENIC DIFFERENTIATION OF BONE MARROW MESENCHYMAL STEM CELLS VIA p38MAPK PATHWAY].
    Zhang K; Liu G; Tian F; Zhang L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2016 Aug; 30(8):1038-1043. PubMed ID: 29786238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical plasma concentration of vinpocetine does not affect osteogenic differentiation of mesenchymal stem cells.
    Yıldırım E; Sezer G
    Pharmacol Rep; 2021 Feb; 73(1):202-210. PubMed ID: 32865810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.